You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 701 to 725 of about 5895
Next 25
05/16/2021
GT Medical Technologies Announces First Patient Has Been Enrolled In Clinical Trial Evaluating GammaTile® Therapy In Patients With Metastatic Brain Tumors
05/11/2021
Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment
Foucused Ultrasound Webinar added to our video library!
05/09/2021
National Walks To End Brain Tumors
Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study
Focused Ultrasound Webinar Tonight! (Sunday 5/9/21)
Focused Ultrasound Webinar now posted to website!
05/08/2021
Medicenna posts positive data from mid-stage brain cancer study
Dabrafenib-trametinib combination active in BRAF V600E-mutant glioma
Immunotherapy for hard-to-treat cancers ready to move toward clinical trials
05/06/2021
Brain Tumor Awareness Month Webinars continues this Sunday, May 9, 2021 with: Current Status and Future Directions of Focused Ultrasound for Brain Tumors
05/04/2021
The efficacy of dendritic cell vaccine for newly diagnosed glioblastoma: a meta-analysis of randomized controlled studies
05/02/2021
Brain Tumor Awareness Month Webinars Start tonight (Sunday May 2, 2021)!
04/29/2021
Brain Tumor Awareness Month Webinars!
xCures launches xACCESS for Providers
04/25/2021
Curing Benign Paroxysmal Positional Vertigo in Patients With Brain Tumor: Case Series and Literature Review
04/23/2021
Musella Foundation Copay Program now closed to new and renewal patients
10th Annual National Walk to End Brain Tumors and Silent Auction
04/22/2021
IQAI commits to Phase1 study for drug candidate in the treatment of Glioblastoma (GBM), a grade IV brain tumor
Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas
04/20/2021
Novel CAR-T shows ‘promising early signs of clinical efficacy’ for diffuse midline gliomas
04/19/2021
Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma
04/15/2021
Treovir’s Oncolytic Virus Product Extends Survival in Children With Brain Tumors
04/14/2021
Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
04/12/2021
Treovir Announces Positive Results of Phase 1 Study of G207 in Pediatric Patients with Recurrent High-Grade Glioma